Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Telo Genomics Corp (TDSGF)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.1150 -0.0010    -0.86%
03/05 - Closed. Currency in USD ( Disclaimer )
  • Volume: 28,680
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.1082 - 0.1547
Type:  Equity
Market:  United States
Telo Genomics 0.1150 -0.0010 -0.86%

Telo Genomics Corp Company Profile

 
Get an in-depth profile of Telo Genomics Corp, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

-

Equity Type

ORD

Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides TeloView-SMM application; TeloView, an analysis software platform for prediction of genomic instability. It has a collaboration agreement with the Mayo Clinic to validate its SMM tests for multiple myeloma. Telo Genomics Corp. is headquartered in Toronto, Canada.

Contact Information

Address MaRS Centre South Tower
Suite 200 101 College Street Toronto, M5G 1L7
Canada
Phone 416-673-8487
Fax -

Top Executives

Name Age Since Title
Hans Knecht - - Member of Clinical & Scientific Advisory Board
William John Meekison 58 2020 Independent Director
Guido Baechler 58 2019 Independent Chairman of the Board
Hugh A. D. Rogers 43 2015 Independent Director
Kenneth C. Anderson 72 2016 Member of Clinical & Scientific Advisory Board
Sabine Mai - 2016 Founder, Interim CEO, Chair of the Clinical & Scientific Advisory Board and Director
Ronald C. McGlennen - 2022 Independent Director
Ivan M. Borrello 59 2024 Member of Clinical Advisory Board
David Samuel diCapua Siegel - 2024 Member of Clinical Advisory Board
Hans Knecht - 2016 Member of Clinical & Scientific Advisory Board
Richard A. Bender - 2022 Member of Clinical Advisory Board
Shaji K. Kumar - 2024 Member of Clinical Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TELO Comments

Write your thoughts about Telo Genomics Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email